Screening for Breast Cancer in Men Has Increased Over Time
Screening for breast cancer in men has increased over time, with high sensitivity and specificity for mammographic screening.
Breast Cancer News
BREAST CANCER ADVISOR
Breast Cancer News
FDA Warns of Possible Interstitial Lung Disease, Pneumonitis With Certain Breast Cancer Drugs
Healthcare professionals are being advised to monitor patients regularly for pulmonary symptoms indicative of ILD and/or pneumonitis, including hypoxia, cough, dyspnea, and interstitial infiltrates on radiologic exams.
Full Chemo Doses May Improve Survival in Breast Cancer
Maintaining full doses of chemo especially important early in the treatment course.
Mammos May Not Benefit Elderly Women With Chronic Illness
Risk for death from other causes much higher than risk for breast cancer death with increasing comorbidity, age.
USPSTF Advises Meds to Reduce Risk for Primary Breast Cancer
Offer risk-reducing meds to women at higher risk for breast cancer, low risk for adverse medication effects.
Germline Testing Should Be Routinely Conducted in Patients With Metastatic Breast Cancer
High prevalence of pathogenic/likely pathogenic variants supports wider testing.
Type and Timing of Menopausal HRT Affect Risk for Breast Cancer
Some excess risk persists for >10 years after ceasing therapy; magnitude varies with duration of use.
Effects of Total Cumulative and Early vs Late Dose Reductions in FEC-D for Early Stage Breast Cancer
In this retrospective study, researchers sought to determine the survival impact of reductions in total cumulative dose and early vs late dose reductions of third-generation adjuvant chemotherapy regimens in patients with early-stage breast cancer.
USPSTF Recommends Genetic Counseling for High BRCA Risk
But counseling not recommended for women without personal, family history, ancestry associated with BRCA mutations.
Rozlytrek, a Tumor Agnostic Therapy, Receives FDA Approval
The Food and Drug Administration (FDA) has granted accelerated approval to Rozlytrek (entrectinib; Genentech).
AI Assists in Reading of Digital Breast Tomosynthesis Images
Concurrent use of AI system improves cancer detection, reduces reading time and recall rate.
Circulating Tumor Cell Clusters, Doublets Do Not Inform Patient Care in Metastatic Breast Cancer
Total number of CTCs, rather than the presence of clusters, may be more prognostically important.
Breast Cancer Surgery + Another Procedure Ups Complications
Findings for women undergoing additional plastic or gynecological procedure at time of breast cancer surgery.
Germline BRCA2 Mutations Linked to Pediatric Lymphomas
Survivors of NHL should be offered genetic counseling.
CDK4/6 Inhibitors Should Be Standard First-Line Treatment for Metastatic HR+ Breast Cancer, Concludes Expert
Emerging overall survival data show a benefit of this type of drug across a variety of patient subgroups.
Delay in Time to Chemo Impacts Survival in Breast Cancer
Time interval from diagnosis to surgery has largest impact on time from diagnosis to chemo initiation.
Biosimilars Mvasi, Kanjinti Now Available in the US
Mvasi (bevacizumab-awwb), a biosimilar to Avastin (bevacizumab), and Kanjinti (trastuzumab-anns), a biosimilar to Herceptin (trastuzumab) have been made available by Amgen and Allergan.
Risk Factors for CVD More Common in Postmenopausal Women Who Survived Breast Cancer
Researchers compared the development of specific CVD risk factors in postmenopausal women who survived breast cancer and women without history of breast cancer.
Physicians Unaware of Breast Density Laws, Cancer Risk
Physicians need more education about breast density and breast cancer screening.
Prospective Evidence Links Textured Breast Implants to Rare Lymphoma
The risk of breast implant-associated anaplastic large cell lymphoma may be higher than previously reported for women who receive textured implants, according to researchers.
Want to read more?
Please login or register first to view this content.
Next post in Breast Cancer
